Eutilex has successfully developed Immunotherapeutics platforms which are proven effective as compared to existing solutions. Their various platform technologies can be applied for treating diverse incurable diseases including solid cancer. Eutilex is currently looking for license/ sale of their technology(ies) and/or for allied collaborations.
For more details about the technology: Click Here